In 2010 I calculated (for a Christian Aid report) that if Zambia had received in 2008 the same export prices in each copper category as had been declared on Swiss exports, then Zambia’s recorded GDP would have been 80 percent bigger.
The International Initiative for Impact Evaluation (3ie) has announced that Emmanuel (Manny) Jimenez will be the organization’s new Executive Director starting in early 2015. The selection of Jimenez represents a key transition for 3ie, which has moved quickly from start-up to maturity in just six years.
The World Bank is in the process of reforming its procurement system, the set of rules that borrowers have to follow when they use Bank financing to buy goods and services. Most of the proposals sound very sensible: much less “prior review” of the process for smaller contracts (World Bank staff looking over bid documents, evaluation reports, and contract documents before they are finalized); more flexibility to use other people’s procurement systems if they’re high quality; more flexibility to use quality alongside cost in evaluating bids in return for greater transparency.
CGD and the Brookings Institution recently released the third edition of the Quality of Official Development Assistance (QuODA), a joint venture that measures donor performance across a series of aid quality indicators to encourage governments, institutions, and agencies to disburse more effective, transparent, and efficient assistance.
TPP? TTIP? In the world of trade negotiations, there is no shortage of acronyms. And who better to break them down for us than Harsha Singh, former deputy director general at the World Trade Organization?
CGD and its health team express our condolences to the families of all lost on MH17. We know that many of those attending the International AIDS Conference, which starts this week-end in Melbourne, have been touched personally by the AIDS researchers and activists lost on the plane and will deeply feel their loss.
There’s no doubt that Treatment as Prevention (TasP) will receive continued emphasis at this year’s International Aids Conference (IAC), as advocates argue for aggressively expanding treatment from the 9 million worldwide currently on antiretrovirals (ARVs) to the 35 million people who are HIV infected. But at the TasP workshop in Vancouver last month the more challenging and novel topic was pre-exposure prophylaxis, or PrEP. A whole array of sessions on PrEP is already on the agenda for next week’s conference in Melbourne, and our bet is that PrEP will generate a lot of buzz – an approach with intriguing potential, but edgy downside possibilities.